
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Intrinsic Value
The intrinsic value of one
AUPH
stock under the Base Case scenario is
10.72
USD.
Compared to the current market price of 8.12 USD,
Aurinia Pharmaceuticals Inc
is
Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Aurinia Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Aurinia Pharmaceuticals Inc
Balance Sheet Decomposition
Aurinia Pharmaceuticals Inc
Current Assets | 446.6m |
Cash & Short-Term Investments | 358.4m |
Receivables | 36.5m |
Other Current Assets | 51.6m |
Non-Current Assets | 104m |
PP&E | 98.9m |
Intangibles | 4.4m |
Other Non-Current Assets | 823k |
Free Cash Flow Analysis
Aurinia Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Aurinia Pharmaceuticals Inc
Revenue
|
235.1m
USD
|
Cost of Revenue
|
-28.2m
USD
|
Gross Profit
|
206.9m
USD
|
Operating Expenses
|
-188.5m
USD
|
Operating Income
|
18.4m
USD
|
Other Expenses
|
-12.7m
USD
|
Net Income
|
5.8m
USD
|
AUPH Profitability Score
Profitability Due Diligence
Aurinia Pharmaceuticals Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Score
Aurinia Pharmaceuticals Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
AUPH Solvency Score
Solvency Due Diligence
Aurinia Pharmaceuticals Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Score
Aurinia Pharmaceuticals Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AUPH
is 10.17 USD
with a low forecast of 8.08 USD and a high forecast of 12.6 USD.
Dividends
Current shareholder yield for AUPH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AUPH
stock under the Base Case scenario is
10.72
USD.
Compared to the current market price of 8.12 USD,
Aurinia Pharmaceuticals Inc
is
Undervalued by 24%.